SGC has more than 250 active research collaborations with academic groups and companies around the world. Below are some of our largest collaboration partners. 

OICR - Ontario Institute for Cancer Research

The Ontario Institute for Cancer Research (OICR) is an innovative cancer research and development institute dedicated to prevention, early detection, diagnosis and treatment of cancer. The Institute is an independent, not-for-profit corporation, supported by the Government of Ontario. OICR's research supports more than 1,700 investigators, clinician scientists, research staff and trainees located at its headquarters and in research institutes and academia across the Province of Ontario. OICR has key research efforts underway in small molecules, biologics, stem cells, imaging, genomics, informatics and bio-computing. For more information, please visit the website at

Eurofins Pharma Discovery Services

For more than 40 years, Eurofins Pharma Discovery Services has been a trusted CRO supporting drug discovery from HTS to preclinical stages.  Uniting the expertise of Cerep, Panlabs & Discovery Services, we support efficacy, safety & PK testing with our products and in vitro pharmacology, cell based phenotypic assay, ADME-Tox and in vivo services.

UNC - Center for Integrative Chemical Biology and Drug Discovery

The Center for Integrative Chemical Biology and Drug Discovery at the University of North Carolina at Chapel Hill was created with the mission of bringing dedicated medicinal chemistry expertise to bear on biological targets of therapeutic relevance under investigation by UNC faculty. Synthetic chemists and assay development and compound-profiling scientists work to create dedicated, multidisciplinary project teams with other groups on campus in order to progress targets through the drug discovery and development process. The Center provides leadership of the North Carolina Comprehensive Chemical Biology Center, a member of NCI’s Chemical Biology Consortium. 

Icahn School of Medicine at Mount Sinai

Dr Jian Jin is a professor at the Icahn School of Medicine at Mount Sinai. His laboratory has two main research areas: (1) discovering chemical probes for histone methyltransferases (HMTs); and (2) creating functionally selective ligands of G protein-coupled receptors (GPCRs). For more information:
glqxz9283 sfy39587stf02 mnesdcuix8